Getting Into Wine Collecting

A more than 25-year veteran of the software development industry, Daniel Duic serves as the CEO of Mindscope Cura Staffing Software. In his free time, Daniel Duic enjoys a wide range of hobbies, including wine collecting.

Wine collecting can become rather expensive, but setting a budget when first starting out prevents overspending. Even a small budget of around $300 is enough for new collectors to buy several great bottles. Typically, a collecting budget is spread out over several months, so many beginners can accommodate far larger budgets and greater buying flexibility. Once a budget is set, focus on buying wines that are enjoyable.

Collecting wines with at least two years of aging potential lets collectors see how their wines develop over time. Not all wine categories age well, so doing some research on different types before buying ensures that collectors get a good variety. Asking questions at a local fine wine store and reading wine collecting books helps beginners learn about collecting basics.

Storing wine properly is an important part of collecting; however, professional refrigeration is not necessary for everyone. If the collector doesn’t have access to a storage location that stays cool year round, investing in a temperature-controlled wine fridge may be necessary. The best storage temperature is around 55 degrees since it allows wine to continue to age while still maximizing its life span.

The Leukemia & Lymphoma Society Exceeds $1 Billion Research Investment

The CEO of Mindscope Cura Staffing Software, Daniel Duic, has more than 25 years of experience in the software development industry. Daniel Duic gives back to his community through charitable contributions to the Leukemia & Lymphoma Society (LLS), a nonprofit health agency committed to blood cancer research and support services.

At LLS’s recent, 3-day conference in Washington, D.C, the organization announced that it surpassed $1 billion in blood cancer research investment. The organization recognized this significant landmark in its history amidst a conference at which leading researchers presented new insights into promising therapies. Discussion panels featured patient testimonials and reviews of patient access to new treatments. One focus of the conference was to encourage more than 500 LLS advocates to meet with and petition government officials in an effort to encourage support of legislation that improves treatment affordability.

Reflecting on the work still to be performed, the LLS interim president, CEO, and chief mission officer emphasized the importance of LLS’ endeavors: “While the one billion dollar research investment is helping to save lives today and extending survival rates for many patients, there are still few, if any, means for preventing or early screening for most blood cancers. More than one third of blood cancer patients do not survive more than five years after diagnosis.”